New potential instrument to fight hepatocellular cancer by restoring p53 (Q39018547)

8 September 2017

0 references

New potential instrument to fight hepatocellular cancer by restoring p53 (English)

1 reference

8 September 2017

hepatocellular carcinoma

1 reference

2

Marek J Los

1 reference

8 September 2017

Franklin C Vincent

1

1 reference

PMCID

3212775

8 September 2017

language of work or name

English

0 references

publication date

1 May 2011

1 reference

8 September 2017

1 reference

8 September 2017

11

1 reference

8 September 2017

5

1 reference

8 September 2017

331-332

1 reference

The effect of desacetyluvaricin on the expression of TLR4 and P53 protein in Hepg 2.2.15.

8 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3212775

Alcohol, nutrition and liver cancer: role of Toll-like receptor signaling

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3212775

Toll-like receptors: cost or benefit for cancer?

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3212775

Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3212775

Design of clinical trials for therapeutic cancer vaccines development

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3212775

The use of coiled-coil proteins in drug delivery systems.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3212775

Cancer stem cell markers in common cancers - therapeutic implications

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3212775

Paw paw and cancer: annonaceous acetogenins from discovery to commercial products

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3212775

Cancer stem cells as targets for cancer therapy: selected cancers as examples.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3212775

Molecular mechanism of viral hepatocarcinogenesis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3212775

Annonaceous acetogenins: recent progress

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3212775

Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3212775

Natural products as a source of potential cancer chemotherapeutic and chemopreventive agents

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3212775

An efficient approach for the isolation, identification and evaluation of antimicrobial plant components on an analytical scale, demonstrated by the example of Radix imperatoriae.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3212775

New, exciting developments in experimental therapies in the early 21st century.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3212775

Activation of intracellular signaling by hepatitis B and C viruses: C-viral core is the most potent signal inducer.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3212775

Liver-specific enhancer II is the target for the p53-mediated inhibition of hepatitis B viral gene expression.

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3212775

Tryptamine derived amides and acetogenins from the seeds of Rollinia mucosa

21 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22087156

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22087156

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

PMCID

3212775

1 reference

8 September 2017

1 reference

PMCID

3212775